Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 6, 2001, Pages 1078-1083

  Sugano, T ^a   Tsuji, Hajime ^a   Masuda, H ^a   Nishimura, H ^a   Yoshizumi, M ^a   Kawano, H ^a   Kimura, S ^a   Ukimura, N ^a   Yano, S ^a   Kunieda, Y ^a   Nakagawa, K ^a   Nakagawa, M ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Adrenomedullin; Angiotensin II; Plasminogen activator inhibitor 1; Tissue factor; Vascular endothelial cells

Indexed keywords

8 BROMO CYCLIC AMP; ADRENOMEDULLIN; ANGIOTENSIN; ARGININE; CYCLIC AMP; FORSKOLIN; NITRIC OXIDE SYNTHASE INHIBITOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN;

ANIMAL CELL; AORTA; ARTICLE; BLOOD CLOTTING; CELL CULTURE; CELL LEVEL; CONCENTRATION RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; FIBRINOLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 0035716610     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.6.1078     Document Type: Article

References (45)

1. Adrenomedullin: A novel hypotensive peptide isolated from human pheochromocytoma
2. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin
3. Mechanisms of adrenomedullin-induced vasodilatation in the rat kidney
4. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells
5. Adrenomedullin is a potent inhibitor of angiotensin II-induced migration of human coronary artery smooth muscle cells
6. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure
7. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure
8. Plasma adrenomedullin and natriuretic peptides in patients with essential or malignant hypertension
9. Angiotensin II increases plasminogen activator inhibitor-1 and tissue factor mRNA expression without changing that of tissue type plasminogen activator or tissue factor pathway inhibitor in cultured rat aortic endothelial cells
10. The regulation of natural anticoagulant pathways
11. Tissue factor and hemostasis
12. Regulation of endothelial cell coagulant properties: Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor
13. Plasminogen activator inhibitor type 1 in ischemic cardiomyopathy
14. Thrombogenic factors and recurrent coronary events
15. Atrial natriuretic peptide inhibits the expression of tissue factor and plasminogen activator inhibitor 1 induced by angiotensin II in cultured rat aortic endothelial cells
16. Isolation and characterization of vasoformative endothelial cells from the rat aorta
17. Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrata
18. Effect of clonal senescence on low density lipoprotein-receptor activity of bovine arterial endothelial cells
19. Cloning and sequencing of cDNA for the rat plasminogen activator inhibitor-1
20. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene
21. Inhibitory effect of adrenomedullin (ADM) on the aldosterone response of human adrenocortical cells to angiotensin-II: Role of ADM(22-52)-sensitive receptors
22. Adrenomedullin dilates rat pulmonary artery rings during hypoxia: Role of nitric oxide and vasodilator prostaglandins
23. Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat
24. Increased plasma adrenomedullin levels in chronic congestive heart failure
25. Increased plasma adrenomedullin in acute myocardial infarction
26. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine
27. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat
28. Regulation of PAMP and adrenomedullin receptor expression in the rat adrenal zona glomerulosa
29. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP)
30. Rat receptor-activity-modifying proteins (RAMPs) for adrenomedullin/CGRP receptor: Cloning and upregulation in obstructive nephropathy
31. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues
32. Adrenomedullin receptors in rat cerebral microvessels
33. Adrenomedullin sensitive receptors are preferentially expressed in cultured rat mesangial cells
34. Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells
35. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells
36. Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells
37. Pulmonary vasodilator responses to adrenomedullin are reduced by NOS inhibitors in rats but not in cats
38. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes
39. 2+ mobilization, in bovine aortic endothelial cells
40. Regional haemodynamic effects of human and rat adrenomedullin in conscious rats
41. Natriuretic peptides regulate the expression of tissue factor and PAI-1 in endothelial cells
42. Role of nitric oxide-cGMP pathway in adrenomedullin-induced vasodilation in the rat
43. Type 1 plasminogen activator inhibitor
44. Structure of the human plasminogen activator inhibitor 1 gene: Nonrandom distribution of introns